| Document Date: 2014-09-17 08:44:02
Open Document File Size: 90,79 KBShare Result on Facebook
City Burgdorf / / Company Finox AG / Finox Biotech / / Continent Europe / / Country Switzerland / United States / / / Event FDA Phase / General or Shareholder Meeting / / IndustryTerm biopharmaceutical / reference product / delivery devices / injector device / / Organization European Medicines Agency / FDA / European Union / / Person Willy Michel / Gavin Jelic-Masterton / / / Position CEO / majority shareholder / President of the Board / / Product Gonal-f / Authorisation Application / BEMFOLA® / USA / FIN3002 / / Technology recombinant DNA technology / drug development / / URL www.finoxbiotech.com / /
SocialTag |
Burgdorf, Switzerland, September 17th, 2014 PRESS RELEASE Finox Biotech Shareholders Agree on 20MCHF Capital Raise FINOX Biotech (Finox AG) announced today that at a meeting of shareholders a